Business
OTC Markets Group Welcomes Marina Biotech to OTCQB
OTC Markets Group Welcomes Marina Biotech to OTCQB.
About this update from Adhera Therapeutics Inc.
[{"type":"text","content":"OTC Markets Group Inc. (OTCQX: OTCM), operator of Open, Transparent and Connected financial marketplaces, today announced Marina Biotech, Inc. (OTCQB: MRNA) is verified for trading on OTCQB®, the venture marketplace for entrepreneurial and development stage companies, as of September 17, 2014. Marina Biotech is a biotechnology company focused on the discovery, development and commercialization of nucleic acid-based therapies to treat orphan diseases. U.S. investors can find current financial disclosure and Real-Time Level 2 quotes for the company on www.otcmarkets.com. About OTC Markets Group Inc.OTC Markets Group Inc. (OTCQX: OTCM) operates Open, Transparent and Connected financial marketplaces for 10,000 U.S. and global securities. Through our OTC Link® ATS, we directly link a diverse network of broker-dealers that provide liquidity and execution services for a wide spectrum of securities. We organize these securities into marketplaces to better inform investors of opportunities and risks – OTCQX®, The Best Marketplace; OTCQB®, The Venture Marketplace; and OTC Pink®, The Open Marketplace. Our data-driven platform enables investors to easily trade through the broker of their choice at the best possible price and empowers a broad range of companies to improve the quality and availability of information for their investors. To learn more about how we create better informed and more efficient financial marketplaces, visit www.otcmarkets.com.OTC Link ATS is operated by OTC Link LLC, member FINRA/SIPC and SEC regulated ATS. Subscribe to the OTC Markets RSS Feed Media Contact:Saskia Sidenfaden, OTC Markets Group Inc., +1 (212) 896-4428, [email protected]","length":7023,"tagName":"div"}]